1. Home
  2. HCAT vs ZVRA Comparison

HCAT vs ZVRA Comparison

Compare HCAT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • ZVRA
  • Stock Information
  • Founded
  • HCAT 2008
  • ZVRA 2006
  • Country
  • HCAT United States
  • ZVRA United States
  • Employees
  • HCAT N/A
  • ZVRA N/A
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCAT Technology
  • ZVRA Health Care
  • Exchange
  • HCAT Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • HCAT 464.4M
  • ZVRA 458.5M
  • IPO Year
  • HCAT 2019
  • ZVRA 2015
  • Fundamental
  • Price
  • HCAT $5.90
  • ZVRA $7.70
  • Analyst Decision
  • HCAT Buy
  • ZVRA Strong Buy
  • Analyst Count
  • HCAT 11
  • ZVRA 7
  • Target Price
  • HCAT $11.45
  • ZVRA $21.20
  • AVG Volume (30 Days)
  • HCAT 551.9K
  • ZVRA 532.5K
  • Earning Date
  • HCAT 02-20-2025
  • ZVRA 11-12-2024
  • Dividend Yield
  • HCAT N/A
  • ZVRA N/A
  • EPS Growth
  • HCAT N/A
  • ZVRA N/A
  • EPS
  • HCAT N/A
  • ZVRA N/A
  • Revenue
  • HCAT $302,062,000.00
  • ZVRA $24,489,000.00
  • Revenue This Year
  • HCAT $6.04
  • ZVRA N/A
  • Revenue Next Year
  • HCAT $11.19
  • ZVRA $384.62
  • P/E Ratio
  • HCAT N/A
  • ZVRA N/A
  • Revenue Growth
  • HCAT 4.15
  • ZVRA 47.85
  • 52 Week Low
  • HCAT $5.42
  • ZVRA $4.20
  • 52 Week High
  • HCAT $11.06
  • ZVRA $9.76
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 28.81
  • ZVRA 34.97
  • Support Level
  • HCAT $6.83
  • ZVRA $8.10
  • Resistance Level
  • HCAT $7.65
  • ZVRA $8.72
  • Average True Range (ATR)
  • HCAT 0.44
  • ZVRA 0.36
  • MACD
  • HCAT -0.08
  • ZVRA -0.06
  • Stochastic Oscillator
  • HCAT 3.31
  • ZVRA 6.72

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: